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ULTRASOUND IN SELECTION OF PATIENTS WITH
ISCHEMIC STROKE FOR THROMBOLYSIS
Andrei V. Alexandrov
STAT Neurosonology Service, Stroke Program, University of Texas, Houston, Texas, USA
SUMMARY · Transcranial Doppler (TCD) in acute ischemic stroke can be used as a convenient
screening test to identify the level of arterial occlusion and presence of residual flow, and to monitor
recanalization. It can help to minimize the number of invasive angiograms and facilitate fast diag-
nostic work-up of stroke patients. Clinical recovery in tissue plasminogen activator (TPA) treated
patients is associated with early complete recanalization. Dramatic clinical recovery during TPA in-
fusion was seen in 20% of patients when TPA was combined with continuous TCD monitoring of
the occlusion site. Ultrasonic energy transmission by TCD monitoring may expose more clot surface
to residual blood flow and thus facilitate thrombolysis.
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The National Institute of Neurological Disorders and
Stroke (NINDS) recombinant tissue plasminogen (rt-PA)
Stroke Study has established a 13% absolute difference in
favorable outcome at 3 months if patients were treated
within 3 hours after stroke onset with 0.9 mg/kg TPA
compared to placebo1. Thrombolysis is administered af-
ter a patient meets (among other criteria) the following
major criteria:
1. time of onset <3 hours (TPA bolus must be given
under 3 hours);
2. measurable neurological deficit (the National Insti-
tutes of Health (NIH) Stroke Scale score ≥4); and
3. no hemorrhage or hypo-attenuation on non-con-
trast CT scan.
Any additional test should not delay administration of
TPA therapy once the decision has been made based on
these major criteria.
Intravenous TPA therapy is beneficial if patients have
been selected strictly following the NINDS protocol with
blood pressure kept under control. Moreover, expert head
CT reading and fast blood work-up are required. Unfor-
tunately, the NINDS rt-PA Stroke Study did not use any
vascular imaging protocol and the question remains
whether all patients who meet these criteria should be
treated with intravenous thrombolysis. Rapid ultrasound
assessment in the emergency room offers a fast, reliable,
and convenient way to diagnose the presence of arterial
occlusion. This information may help understand the
pathogenic mechanism of stroke and make individual
management decisions:
1. selection of patients for angiography (minimize
false-negative studies);
2. determination of the next most informative urgent
diagnostic test (echocardiography, Holter monitor, ca-
rotid/vertebral scanning);
3. select optimal blood pressure management, head po-
sition, hydration/volume expansion in patients with ca-
rotid or other large vessel occlusion;
4. identification of embolic sources and individualiz-
ing secondary prevention; and
5. other therapeutic decisions based on improved dif-
ferential diagnosis of stroke mechanism and localization.
The Stroke Treatment Team, University of Texas ·
Houston, routinely use transcranial Doppler (TCD) to
identify the site of arterial occlusion within the first
hours of ischemic stroke and continuously monitor re-
perfusion2,3. TCD can help select patients for intra-ar-
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terial thrombolysis by minimizing false-negative angio-
graphic studies4. In our series, TCD showed sensitivity
for proximal internal carotid artery occlusion of 94%, for
M1-M2 middle cerebral artery occlusion of 93%, with
specificity of 96% · 98%4.
Residual Flow Signals
In patients receiving intravenous TPA, TCD can de-
termine residual flow signals at the site of clot location3.
In analogy to the Thrombolysis in Myocardial Infarction
(TIMI) flow grades that predict the success of coronary
thrombolysis5, we developed the Thrombolysis in Brain
Infarction (TIBI) flow grades based on TCD waveforms
obtained at the site of intracranial occlusion. TIBI grade
1 consisted of absent and minimal flow signals, TIBI grade
2 of blunted and dampened, and TIBI grade 3 of stenotic
and normal flow signals6. In this study, 109 patients treated
with intravenous TPA were studied (mean age 68±16
years, median pre-TPA NIH Stroke Scale score (NIHSS)
17.5 points). TPA bolus was given at 143±58 min after
symptom onset and TCD examination was performed at
141±57 min after symptom onset. Pre-TPA NIHSS were
higher in TIBI grade 0 flow than in TIBI grade 4 or 5 flow.
TIBI flow improvement to grade 4 or 5 occurred in 35%
(19/54) of initial grade 0 or 1, and in 52% (12/23) of ini-
tial grade 2 or 3 patients. Twenty-four hour NIHSS were
higher in follow-up TIBI grade 0 or 1 flow than in TIBI
grade 4 or 5 flow, whereas the lack of flow recovery pre-
dicted worsening or no improvement. In-hospital mortal-
ity was 22% (11/51) for pre-TPA TIBI 0 or 1 and 5% (1/
19) for pre-TPA 2 or 3 in patients with anterior circula-
tion occlusion. Therefore, emergent TCD TIBI classifi-
cation correlates with initial stroke severity, clinical recov-
ery, and mortality in intravenous TPA treated stroke pa-
tients. A flow grade improvement on TCD correlates with
clinical improvement. This simple scoring system can be
used to characterize residual flow signals and optimize cri-
teria for recanalization after thrombolysis.
TCD Assessment of Recanalization
TCD accuracy for identification of middle cerebral
artery (MCA) recanalization after TPA therapy was as-
sessed in 27 patients by comparison to digital subtraction
angiography or magnetic resonance angiography. TCD
had sensitivity of 91%, specificity of 93%, positive predic-
tive value of 91%, and negative predictive value of 93% for
complete MCA recanalization. Partial TCD flow grade
improvement (TIBI 1 to 2) should be interpreted as per-
sistent occlusion compared with angiography7.
TCD Monitoring of TPA Therapy for Ischemic
Stroke
We prospectively implemented a single channel 2
MHz continuous TCD monitoring of the intracranial
occlusion site during TPA infusion (Multigon 500M,
MultiDop-T and EZ-Dop, DWL/Neuroscan, Marc se-
ries headframe, Spencer Technologies)3. We monitored
the entire TPA infusion focusing TCD beam on the lo-
cation of the worst TIBI residual flow signals. We assessed
40 patients (age 70±16 years, baseline NIHSS 18.6±6.2,
intravenous TPA bolus at 132±54 min from symptom
onset). TCD monitoring started at 125±52 min and con-
tinued for the duration of TPA infusion. MCA was oc-
cluded in 30 patients, ICA in 11, basilar in three, multiple
occlusions in seven; 4 patients had no windows, and one
patient had a normal TCD before TPA bolus. Recanali-
zation on TCD was found at 45±20 min after TPA bo-
lus: complete recanalization in 12 (30%) and partial in 16
(40%) patients. Dramatic recovery during TPA infusion
(total NIHSS score <3) occurred in eight (20%) of all
patients (baseline NIHSS range 6-22; all of them had
complete recanalization). The lack of improvement or
worsening was associated with no recanalization, late re-
canalization, or reocclusion on TCD (coefficient of con-
tingency, C = 0.811, p ≤0.01). Improvement by ≥10
NIHSS points or complete recovery was found in 30% of
all patients at the end of TPA infusion and in 40% at 24
hours. Improvement by ≥4 NIHSS points was found in
62.5% of patients at 24 hours. Therefore, we observed
dramatic recovery during TPA therapy in 20% of all pa-
tients when infusion was continuously monitored by
TCD. Recovery was associated with recanalization on
TCD, while no early improvement indicated persisting
occlusion or reocclusion. At 24 hours, 40% of all patients
improved by ≥10 NIHSS points or recovered completely.
Ultrasonic energy transmission by TCD monitoring may
expose more clot surface to TPA and facilitate thromboly-
sis, and deserves a controlled trial as a way to potentiate
the effect of TPA therapy3.
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Patient Eligibility for Combined Intravenous and
Intra-arterial Thrombolysis
Persisting arterial occlusion is a poor prognostic sign
in patients with acute ischemic stroke8-10. A recent study
has demonstrated feasibility of a combined approach that
includes intravenous thrombolysis followed by intra-arte-
rial delivery of TPA11. Since intravenous TPA bolus ad-
ministration is the fastest way of initiating thrombolysis,
this approach should be reserved for patients with occlu-
sion persisting at the end of TPA infusion (note a 30%
complete recanalization rate4). Therefore, to avoid inva-
sive angiography in patients with early recanalization, a
quick noninvasive screening test should be used in the
emergency room. For example, in the Prolyse in Acute
Cerebral Thromboembolism Trial (PROACT)12, 12,323
patients were evaluated clinically and with noncontrast
CT scan to identify MCA occlusion. This method of
screening led to 476 angiograms (16:1 ratio), of which only
180 were found to have M1-M2 MCA occlusions (2.6:1
ratio). An experienced TCD user can rapidly identify pa-
tients with M1-MCA occlusion with sensitivity and speci-
ficity exceeding 90%. With these accuracy parameters,
TCD screening can help reduce the number of negative
invasive angiograms and allow cost containment in the
application of intra-arterial therapies4,6.
Deterioration Following Improvement
Patients with acute symptoms of stroke often sponta-
neously improve only to deteriorate minutes or hours later.
We prospectively studied patients who presented with a
focal neurologic deficit spontaneously resolving within six
hours of symptom onset13. Patients were evaluated using
bedside TCD and angiography when feasible. Deteriora-
tion following improvement (DFI) was determined as
subsequent worsening of the neurologic deficit by ≥4 NIH
Stroke Scale points within 24 hours of the initial symp-
tom onset. We studied 50 consecutive patients presenting
at 165±96 minutes from symptom onset. Mean age was
61±14 years, and 50% were females. All patients had TCD
at the time of presentation and 68% had subsequent
angiographic examinations (DSA 10%, CTA 4%, and
MRA 44%). Overall, large vessel occlusion on TCD was
found in 16% (n = 8) and stenosis in 18% (n = 9) of pa-
tients, whereas 54% (n = 27) of patients had normal stud-
ies; six (12%) patients had no temporal windows. DFI
occurred in 16% (n = 8) of the 50 patients: in 62% of pa-
tients with TCD and angiographic evidence of occlusion,
in 22% of patients with stenosis, and in 4% of those with
normal vascular studies (p<0.001, φ = 0.523, φ2 = 12.05).
DFI occurred in 31% of patients with large vessel athero-
sclerosis, 23% with cardioembolism, and 9% with small
vessel disease when stroke mechanisms were determined
within 2-3 days after admission (p = 0.2, ns).
In this study13, DFI was strongly associated with the
presence of large vessel occlusion or stenosis of either ath-
erosclerotic or embolic origin. Normal vascular studies and
lacunar events were associated with stable spontaneous
resolution without subsequent fluctuation. Urgent vascu-
lar evaluation may help identify patients with resolving
deficits and vascular lesions who may be candidates for
new therapies to prevent subsequent deterioration.
Conclusion
TCD in acute ischemic stroke can be used as a conve-
nient screening test to identify the level of arterial occlu-
sion and presence of residual flow, and to monitor recanali-
zation. It can help minimize the number of invasive
angiograms and facilitate fast diagnostic work-up of stroke
patients. Clinical recovery in TPA treated patients is asso-
ciated with early complete recanalization. Dramatic clini-
cal recovery during TPA infusion was seen in 20% of pa-
tients when TPA was combined with continuous TCD
monitoring of the occlusion site. Ultrasonic energy trans-
mission by TCD monitoring may expose more clot surface
to residual blood flow and thus facilitate thrombolysis.
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Saæetak
PRIMJENA ULTRAZVUKA PRI IZBORU BOLESNIKA S ISHEMIJSKIM
MOÆDANIM UDAROM ZA TROMBOLITI»KU TERAPIJU
A. V. Alexandrov
U bolesnika s akutnim ishemijskim moædanim udarom transkranijski dopler (TCD) moæe se upotrijebiti kao prikladna
metoda za identifikaciju stupnja arterijske okluzije, prisutnosti rezidualnog protoka kao i za monitoriranje rekanalizacije. TCD
moæe pomoÊi u smanjivanju broja invazivnih angiografija i moæe olak¹ati brzu dijagnostiËku obradu bolesnika s moædanim
udarom. KliniËki oporavak bolesnika koji su lijeËeni s tkivnim plazminogen aktivatorom (TPA) povezan je s ranom potpunom
rekanalizacijom. DramatiËni kliniËki oporavak za vrijeme infuzije TPA primijeÊen je u 20% bolesnika kada je TPA primijenjen
istovremeno s kontinuiranim TCD monitoriranjem okludirane æile. UltrazvuËna energija koja se prenosi TCD monitoriranjem
moæe izloæiti veÊu povr¹inu ugru¹ka rezidualnom protoku krvi i na taj naËin olak¹ati trombolizu.
KljuËne rijeËi: Moædana ishemija, ultrasonografija; Moædana ishemija, terapija; TrombolitiËka terapija; Ultrasonografija, Doppler,
transkranijski
